MR Enteroclysis in Crohns Disease

Anti-Interleukin-6 Therapy for Crohns Disease

Current Pharmaceutical Design ◽

10.2174/1381612033391900 ◽

2003 ◽

Vol 9 (4) ◽

pp. 295-305 ◽

Cited By ~ 26

Author(s):

H. Ito

Keyword(s):

Interleukin 6 ◽

Crohns Disease

Get full-text (via PubEx)

Contrast enhanced ultrasound: a new safe, bedside method of characterizing ileal strictures in children with Crohns disease

Journal of Clinical Gastroenterology and Hepatology ◽

10.21767/2575-7733-c2-004 ◽

2018 ◽

Vol 02 ◽

Author(s):

Carmen Cuffari

Keyword(s):

Contrast Enhanced Ultrasound ◽

Crohns Disease ◽

Contrast Enhanced ◽

Bedside Method

Get full-text (via PubEx)

Tu1934 Assessment of Serum C-Reactive Protein, Fecal Lactoferrin, and Fecal Calprotectin in Patients With Moderate-Severely Active Crohns Disease: Results From the IM UNITI Maintenance Study

Gastroenterology ◽

10.1016/s0016-5085(16)33327-3 ◽

2016 ◽

Vol 150 (4) ◽

pp. S982

Author(s):

William Sandborn ◽

Christopher Gasink ◽

Douglas Jacobstein ◽

Long-Long Gao ◽

Jewel Johanns ◽

...

Keyword(s):

Fecal Calprotectin ◽

C Reactive Protein ◽

Crohns Disease ◽

Reactive Protein ◽

Fecal Lactoferrin ◽

Maintenance Study

Get full-text (via PubEx)

ORAL PRESENTATION OF CROHNS DISEASE WITH KAPPA-RESTRICTED PLASMA CELLS IN A PEDIATRIC PATIENT

Oral Surgery Oral Medicine Oral Pathology and Oral Radiology ◽

10.1016/j.oooo.2017.06.087 ◽

2017 ◽

Vol 124 (3) ◽

pp. e223-e224

Author(s):

A. ECKEL ◽

D. ODA

Keyword(s):

Pediatric Patient ◽

Oral Presentation ◽

Plasma Cells ◽

Crohns Disease

Get full-text (via PubEx)

Mo1668 Mucosal Healing is a Cost-Effective Endpoint With Biologic Therapy in Crohns Disease - Results From a Decision Analysis

Gastroenterology ◽

10.1016/s0016-5085(12)62523-2 ◽

2012 ◽

Vol 142 (5) ◽

pp. S-654 ◽

Cited By ~ 1

Author(s):

Ashwin N. Ananthakrishnan ◽

Joshua R. Korzenik ◽

Chin Hur

Keyword(s):

Decision Analysis ◽

Biologic Therapy ◽

Cost Effective ◽

Mucosal Healing ◽

Crohns Disease

Get full-text (via PubEx)

An evaluation of clinical remission and safety among Biologics for moderate-to-severe crohns disease: a Bayesian Network meta-analysis

Value in Health ◽

10.1016/j.jval.2015.03.1287 ◽

2015 ◽

Vol 18 (3) ◽

pp. A221-A222

Author(s):

M. Bounthavong ◽

Y.H. Bae ◽

D.J. Vanness ◽

R. Kazerooni ◽

B. Devine

Keyword(s):

Bayesian Network ◽

Clinical Remission ◽

Meta Analysis ◽

Crohns Disease

Get full-text (via PubEx)

Endoscopic and Mucosal Healing in Crohns Disease with Azathioprine

Journal of Clinical and Analytical Medicine ◽

10.4328/jcam.4726 ◽

2016 ◽

Vol 7 (Suppl 3) ◽

Keyword(s):

Mucosal Healing ◽

Crohns Disease

Get full-text (via PubEx)

CT AND MR ENTEROCLYSIS IN THE EVALUATION OF SMALL BOWEL DISEASE

Journal of Evidence Based Medicine and Healthcare ◽

10.18410/jebmh/2015/1130 ◽

2015 ◽

Vol 2 (47) ◽

pp. 8335-8339

Author(s):

Siva Sridhar M ◽

Sai Raghavendra D ◽

Sowjanya D ◽

Manjula Sridhar

Keyword(s):

Small Bowel ◽

Bowel Disease ◽

Small Bowel Disease ◽

Mr Enteroclysis

Get full-text (via PubEx)

Intestinal Tuberculosis and Crohns Disease

Journal of Clinical Case Reports ◽

10.4172/2165-7920.1000578 ◽

2015 ◽

Vol 05 (08) ◽

Keyword(s):

Intestinal Tuberculosis ◽

Crohns Disease

Get full-text (via PubEx)

Tu1234 Granulomas of Intestinal Tuberculosis and Crohns Disease Can Be Differentiated by CD 73 Mesenchymal Cell Surface Marker Expression

Gastroenterology ◽

10.1016/s0016-5085(12)63028-5 ◽

2012 ◽

Vol 142 (5) ◽

pp. S-780-S-781

Author(s):

Rupa Banerjee ◽

M. Balaji ◽

Sasikala Mitnala ◽

Sekaran Anuradha ◽

D. Nageshwar Reddy

Keyword(s):

Cell Surface ◽

Intestinal Tuberculosis ◽

Mesenchymal Cell ◽

Surface Marker ◽

Cell Surface Marker ◽

Crohns Disease ◽

Surface Marker Expression ◽

Marker Expression ◽

Cell Surface Marker Expression

Get full-text (via PubEx)